Head and neck squamous cell carcinoma (HNSCC) is a type of cancer that starts in the cells lining the head and neck. It can occur anywhere in these areas, but it most often occurs on the tongue, tonsils, or throat. HNSCC is one of the most common cancers worldwide. The global head and neck squamous cell carcinoma treatment market is expected to grow at a CAGR of 4.5% during 2018-2030. The global head and neck squamous cell carcinoma treatment market has been segmented on the basis of type into surgical therapy, radiation therapy, drug treatment, and others; by application into hospitals, clinics, ambulatory surgical centers; by region into North America (NA), Latin America (LA), Europe (EU), Asia Pacific (APAC) & Middle East & Africa (MEA). The North American region dominates this market with a share of over 40%.
Some Of The Growth Factors Of This Market:
- Increasing incidence of head and neck cancer, rising awareness about the disease, and increasing adoption of advanced treatment methods are some factors that are driving the growth of the Head And Neck Squamous Cell Carcinoma Treatment market.
- Increasing prevalence of chronic diseases such as diabetes mellitus, obesity, and hypertension is also driving the growth of this market.
- The high cost associated with treatment procedures is a major factor restraining the growth of this market.
- Increasing government initiatives for research in cancer treatments.
Industry Growth Insights published a new data on “Head And Neck Squamous Cell Carcinoma Treatment Market”. The research report is titled “Head And Neck Squamous Cell Carcinoma Treatment Market research by Types (Surgical Therapy, Radiation Therapy, Drug Treatment, Head And Neck Squamous Cell Carcinoma Treatmen), By Applications (Hospitals, Clinics, Ambulatory Surgical Centers), By Players/Companies Amgen, AbbVie, Bristol-Myers Squibb, AstraZeneca, Eli Lilly, GlaxoSmithKline, Teva, Roche, Celgene, Head And Neck Squamous Cell Carcinoma Treatmen”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Head And Neck Squamous Cell Carcinoma Treatment Market Research Report
By Type
Surgical Therapy, Radiation Therapy, Drug Treatment, Head And Neck Squamous Cell Carcinoma Treatmen
By Application
Hospitals, Clinics, Ambulatory Surgical Centers
By Companies
Amgen, AbbVie, Bristol-Myers Squibb, AstraZeneca, Eli Lilly, GlaxoSmithKline, Teva, Roche, Celgene, Head And Neck Squamous Cell Carcinoma Treatmen
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
235
Number of Tables & Figures
165
Customization Available
Yes, the report can be customized as per your need.
Global Head And Neck Squamous Cell Carcinoma Treatment Market Report Segments:
The global Head And Neck Squamous Cell Carcinoma Treatment market is segmented on the basis of:
Types
Surgical Therapy, Radiation Therapy, Drug Treatment, Head And Neck Squamous Cell Carcinoma Treatmen
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Ambulatory Surgical Centers
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Amgen
- AbbVie
- Bristol-Myers Squibb
- AstraZeneca
- Eli Lilly
- GlaxoSmithKline
- Teva
- Roche
- Celgene
- Head And Neck Squamous Cell Carcinoma Treatmen
Highlights of The Head And Neck Squamous Cell Carcinoma Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Surgical Therapy
- Radiation Therapy
- Drug Treatment
- Head And Neck Squamous Cell Carcinoma Treatmen
- By Application:
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Head And Neck Squamous Cell Carcinoma Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
There is no one definitive answer to this question as the best treatment for head and neck squamous cell carcinoma (HNSCC) will vary depending on the specific case. However, some common treatments include surgery, radiation therapy, and chemotherapy.
Some of the key players operating in the head and neck squamous cell carcinoma treatment market are Amgen, AbbVie, Bristol-Myers Squibb, AstraZeneca, Eli Lilly, GlaxoSmithKline, Teva, Roche, Celgene, Head And Neck Squamous Cell Carcinoma Treatmen.
The head and neck squamous cell carcinoma treatment market is expected to grow at a compound annual growth rate of 4.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Head And Neck Squamous Cell Carcinoma Treatment Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Head And Neck Squamous Cell Carcinoma Treatment Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Head And Neck Squamous Cell Carcinoma Treatment Market - Supply Chain
4.5. Global Head And Neck Squamous Cell Carcinoma Treatment Market Forecast
4.5.1. Head And Neck Squamous Cell Carcinoma Treatment Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Head And Neck Squamous Cell Carcinoma Treatment Market Size (000 Units) and Y-o-Y Growth
4.5.3. Head And Neck Squamous Cell Carcinoma Treatment Market Absolute $ Opportunity
5. Global Head And Neck Squamous Cell Carcinoma Treatment Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Head And Neck Squamous Cell Carcinoma Treatment Market Size and Volume Forecast by Type
5.3.1. Surgical Therapy
5.3.2. Radiation Therapy
5.3.3. Drug Treatment
5.3.4. Head And Neck Squamous Cell Carcinoma Treatmen
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Head And Neck Squamous Cell Carcinoma Treatment Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Head And Neck Squamous Cell Carcinoma Treatment Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Clinics
6.3.3. Ambulatory Surgical Centers
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Head And Neck Squamous Cell Carcinoma Treatment Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Head And Neck Squamous Cell Carcinoma Treatment Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Head And Neck Squamous Cell Carcinoma Treatment Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Head And Neck Squamous Cell Carcinoma Treatment Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Head And Neck Squamous Cell Carcinoma Treatment Demand Share Forecast, 2019-2026
9. North America Head And Neck Squamous Cell Carcinoma Treatment Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Head And Neck Squamous Cell Carcinoma Treatment Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Head And Neck Squamous Cell Carcinoma Treatment Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Clinics
9.4.3. Ambulatory Surgical Centers
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Head And Neck Squamous Cell Carcinoma Treatment Market Size and Volume Forecast by Type
9.7.1. Surgical Therapy
9.7.2. Radiation Therapy
9.7.3. Drug Treatment
9.7.4. Head And Neck Squamous Cell Carcinoma Treatmen
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Head And Neck Squamous Cell Carcinoma Treatment Demand Share Forecast, 2019-2026
10. Latin America Head And Neck Squamous Cell Carcinoma Treatment Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Head And Neck Squamous Cell Carcinoma Treatment Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Head And Neck Squamous Cell Carcinoma Treatment Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Ambulatory Surgical Centers
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Head And Neck Squamous Cell Carcinoma Treatment Market Size and Volume Forecast by Type
10.7.1. Surgical Therapy
10.7.2. Radiation Therapy
10.7.3. Drug Treatment
10.7.4. Head And Neck Squamous Cell Carcinoma Treatmen
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Head And Neck Squamous Cell Carcinoma Treatment Demand Share Forecast, 2019-2026
11. Europe Head And Neck Squamous Cell Carcinoma Treatment Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Head And Neck Squamous Cell Carcinoma Treatment Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Head And Neck Squamous Cell Carcinoma Treatment Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Ambulatory Surgical Centers
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Head And Neck Squamous Cell Carcinoma Treatment Market Size and Volume Forecast by Type
11.7.1. Surgical Therapy
11.7.2. Radiation Therapy
11.7.3. Drug Treatment
11.7.4. Head And Neck Squamous Cell Carcinoma Treatmen
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Head And Neck Squamous Cell Carcinoma Treatment Demand Share, 2019-2026
12. Asia Pacific Head And Neck Squamous Cell Carcinoma Treatment Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Head And Neck Squamous Cell Carcinoma Treatment Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Head And Neck Squamous Cell Carcinoma Treatment Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Ambulatory Surgical Centers
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Head And Neck Squamous Cell Carcinoma Treatment Market Size and Volume Forecast by Type
12.7.1. Surgical Therapy
12.7.2. Radiation Therapy
12.7.3. Drug Treatment
12.7.4. Head And Neck Squamous Cell Carcinoma Treatmen
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Head And Neck Squamous Cell Carcinoma Treatment Demand Share, 2019-2026
13. Middle East & Africa Head And Neck Squamous Cell Carcinoma Treatment Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Head And Neck Squamous Cell Carcinoma Treatment Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Head And Neck Squamous Cell Carcinoma Treatment Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Clinics
13.4.3. Ambulatory Surgical Centers
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Head And Neck Squamous Cell Carcinoma Treatment Market Size and Volume Forecast by Type
13.7.1. Surgical Therapy
13.7.2. Radiation Therapy
13.7.3. Drug Treatment
13.7.4. Head And Neck Squamous Cell Carcinoma Treatmen
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Head And Neck Squamous Cell Carcinoma Treatment Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Head And Neck Squamous Cell Carcinoma Treatment Market: Market Share Analysis
14.2. Head And Neck Squamous Cell Carcinoma Treatment Distributors and Customers
14.3. Head And Neck Squamous Cell Carcinoma Treatment Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Amgen
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. AbbVie
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Bristol-Myers Squibb
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. AstraZeneca
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Eli Lilly
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. GlaxoSmithKline
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Teva
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Roche
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Celgene
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Head And Neck Squamous Cell Carcinoma Treatmen
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook